301239 普瑞眼科
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.774-4.63712.2921.36410.423
总资产报酬率 ROA (%)0.355-2.1646.3100.6855.393
投入资产回报率 ROIC (%)0.402-2.4807.1160.7586.344

边际利润分析
销售毛利率 (%)37.11536.98143.99941.67343.372
营业利润率 (%)4.1380.26514.2033.9148.368
息税前利润/营业总收入 (%)6.6222.20515.7076.18510.952
净利润/营业总收入 (%)0.981-3.46610.2291.1925.491

收益指标分析
经营活动净收益/利润总额(%)118.857-17.02082.91180.92794.441
价值变动净收益/利润总额(%)-2.88413.50121.61325.6126.816
营业外收支净额/利润总额(%)-14.057127.308-6.563-14.035-3.026

偿债能力分析
流动比率 (X)1.0740.9671.1652.0400.857
速动比率 (X)0.8450.8021.0191.8550.673
资产负债率 (%)53.51853.86851.85443.77159.224
带息债务/全部投入资本 (%)16.93217.56212.43910.56211.065
股东权益/带息债务 (%)306.539295.879441.914582.388415.128
股东权益/负债合计 (%)86.14884.84591.783128.46268.851
利息保障倍数 (X)2.2110.6946.6022.2473.871

营运能力分析
应收账款周转天数 (天)12.61614.81111.75111.72912.576
存货周转天数 (天)32.64431.97730.64735.34931.719